FULC - Fulcrum Therapeutics, Inc.

📈 Is growth accelerating? 5 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Dec 31, 2017 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-K ↗
Revenue Growth YoY (%)	—	—	—	—	N/M	—	—	N/M	8990.9% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+112286%)	N/M	—	-35.8% Weak ↑ Weak Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-548%)	-53.2% Weak ↑ Weak Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-766%)	-88.6% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1208%)	—	-76.0% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1050%)	-57.0% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-813%)	-45.9% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-673%)	—	167.0% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1988%)	119.0% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1388%)	538.5% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+6632%)	—	—	—	—	—	—	—	—	—	—	—	—	—
EPS Growth YoY (%)	-21.4% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	10.7% Fair ↑ Fair Improving Year-over-year change in earnings per share Optimal: > 10%	-14.8% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	11.4% Fair ↓ Fair Declining Year-over-year change in earnings per share Optimal: > 10%	N/M	34.9% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	32.5% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	10.3% Fair ↑ Fair Improving Year-over-year change in earnings per share Optimal: > 10%	N/M	-4.9% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	14.9% Fair ↓ Fair Declining Year-over-year change in earnings per share Optimal: > 10%	23.5% Good ↓ Good Declining Year-over-year change in earnings per share Optimal: > 10%	54.2% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	—	19.0% Good ↑ Good Improving Year-over-year change in earnings per share Optimal: > 10%	10.5% Fair Fair Year-over-year change in earnings per share Optimal: > 10%	-38.3% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	-7.0% Weak ↓ Weak Declining Year-over-year change in net income	-7.0% Weak ↓ Weak Declining Year-over-year change in net income	-22.7% Weak ↓ Weak Declining Year-over-year change in net income	34.3% Excellent → Excellent Stable Year-over-year change in net income	34.3% Excellent ↑ Excellent Improving Year-over-year change in net income	34.3% Excellent ↑ Excellent Improving Year-over-year change in net income	33.1% Excellent ↑ Excellent Improving Year-over-year change in net income	-8.4% Weak ↓ Weak Declining Year-over-year change in net income	-8.4% Weak ↓ Weak Declining Year-over-year change in net income	-8.4% Weak ↓ Weak Declining Year-over-year change in net income	5.3% Fair ↑ Fair Improving Year-over-year change in net income	4.4% Caution ↑ Caution Improving Year-over-year change in net income	4.4% Caution ↑ Caution Improving Year-over-year change in net income	4.4% Caution ↑ Caution Improving Year-over-year change in net income	-11.3% Weak ↑ Weak Improving Year-over-year change in net income	-52.5% Weak ↓ Weak Declining Year-over-year change in net income	-52.5% Weak ↓ Weak Declining Year-over-year change in net income	-52.5% Weak ↓ Weak Declining Year-over-year change in net income	-32.5% Weak ↓ Weak Declining Year-over-year change in net income	7.9% Fair ↑ Fair Improving Year-over-year change in net income	7.9% Fair ↓ Fair Declining Year-over-year change in net income	7.9% Fair ↓ Fair Declining Year-over-year change in net income	-9.9% Weak ↓ Weak Declining Year-over-year change in net income	49.9% Excellent ↑ Excellent Improving Year-over-year change in net income	49.9% Excellent ↑ Excellent Improving Year-over-year change in net income	49.9% Excellent ↑ Excellent Improving Year-over-year change in net income	-82.0% Weak ↑ Weak Improving Year-over-year change in net income	-430.9% Weak Weak Year-over-year change in net income	-430.9% Weak Weak Year-over-year change in net income	—	—	—	—	—	—
FCF Growth YoY (%)	—	-0.8% Weak Weak Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Revenue CAGR 3Y (%)	—	—	—	—	—	—	—	—	163.3% Excellent Excellent Compound annual revenue growth over 3 years	—	—	-25.7% Weak → Weak Stable Compound annual revenue growth over 3 years	-23.9% Weak Weak Compound annual revenue growth over 3 years	-26.7% Weak Weak Compound annual revenue growth over 3 years	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 4 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Dec 31, 2017 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-K ↗
Operating Margin (%) (%)	—	—	—	—	—	—	—	—	65.6% Excellent Excellent Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+337%)	—	—	—	—	—	—	—	—	—	—	-420.9% Weak → Weak Stable Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2906%)	-449.3% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3095%)	-355.9% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2473%)	—	—	—	—	—	—	—	—	—	—	—	—	—
Profit Margin (%) (%)	—	—	—	—	—	—	—	—	-33.6% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-380%)	—	—	—	—	—	—	—	—	—	—	-344.5% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2970%)	-388.0% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3333%)	-355.0% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3058%)	—	—	—	—	—	—	—	—	—	—	—	—	—
FCF Margin (%) (%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	0.0% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	-464.8% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-419.7% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-344.3% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—	—	—
FCF / Net Income (x)	0.85x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.99x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.83x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.81x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	—	0.86x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	1.03x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	—	—	0.94x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.94x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	—	0.85x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.98x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.76x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	—	0.00x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.86x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.95x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.35x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	1.08x Fair → Fair Stable Free cash flow relative to reported net income Optimal: > 1x	0.97x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	1.15x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	—	—	0.85x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.29x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.36x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.33x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.28x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	1.11x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	0.73x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Dec 31, 2017 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-K ↗
Return on Invested Capital (%)	-7.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-5.3% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-5.1% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-8.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-7.3% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-7.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-6.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-7.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	15.1% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-11.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-9.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-8.5% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-7.8% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-7.5% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-11.1% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-8.7% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-16.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-10.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-8.8% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-7.1% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-14.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-10.5% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-14.8% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-14.4% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-10.3% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-21.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-14.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-13.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	9.5% Fair ↓ Fair Declining Return earned on debt + equity capital invested Optimal: > 10%	29.5% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	11.5% Good ↓ Good Declining Return earned on debt + equity capital invested Optimal: > 10%	12.9% Good Good Return earned on debt + equity capital invested Optimal: > 10%	13.2% Good Good Return earned on debt + equity capital invested Optimal: > 10%	—	—
Return on Capital (%) (%)	-9.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-6.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-6.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-10.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-8.7% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-8.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-7.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-9.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	17.8% Excellent ↑ Excellent Improving Operating profit relative to total assets Optimal: > 10%	-12.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-10.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-9.8% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	—	-8.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-12.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-9.8% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-17.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-11.8% Weak Weak Operating profit relative to total assets Optimal: > 10%	-10.0% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	-10.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-13.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-13.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-11.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-19.8% Weak Weak Operating profit relative to total assets Optimal: > 10%	-14.9% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	-10.8% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—
Return on Common Equity (%) (%)	-6.1% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-141%)	-5.7% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-138%)	-5.8% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-139%)	-8.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-159%)	-8.2% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-155%)	-7.7% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-152%)	-6.8% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-145%)	-10.4% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-170%)	-9.8% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-165%)	-12.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-184%)	-10.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-170%)	-9.7% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-165%)	-9.0% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-160%)	-8.4% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-156%)	-13.1% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-188%)	-11.7% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-178%)	-16.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-208%)	-13.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-191%)	-11.1% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-174%)	-7.4% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-149%)	-15.3% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-202%)	-13.3% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-189%)	-18.6% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-224%)	-17.6% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-217%)	-15.1% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-201%)	-26.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-274%)	-18.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-223%)	-36.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-341%)	33.0% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+120%)	37.0% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+146%)	13.9% Fair → Fair Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-7%)	12.5% Fair Fair Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-17%)	14.7% Fair Fair Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: At sector avg	—	—

⚖️ Is the balance sheet risky? 2 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Dec 31, 2017 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-K ↗
Interest Coverage (x)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	-17787.00x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	-18796.00x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-16490.00x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-8503.00x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-6747.00x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-18613.50x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-4625.50x Weak Weak Operating income divided by interest expense Optimal: > 5x	-3029.33x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—
Net Debt (USD)	$-48.47M	$-50.26M	$-197.53M	$-47.08M	$-42.59M	$-42.18M	$-58.21M	$-72.63M	$-86.70M	$-39.95M	$-25.56M	$-30.08M	$-33.97M	$-34.73M	$-35.10M	$-90.94M	$-40.15M	$-33.31M	$-35.41M	$-65.47M	$-56.78M	$-100.75M	$-57.05M	$-85.22M	$-75.72M	$-25.38M	$-96.71M	$-101.60M	$-49.63M	$-62.45M	$-72.80M	$-82.76M	$-7.98M	—	—

📊 What does each share earn? 6 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Dec 31, 2017 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-K ↗
Revenue per Share (USD)	—	—	—	$0.00	$0.00	—	—	$0.00	$1.29	—	—	—	$0.01	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Basic EPS, GAAP (USD)	$-0.34	$-0.25	$-0.31	$-0.31	$-0.28	$-0.28	$-0.27	$-0.35	$0.89	$-0.43	$-0.40	$-0.39	$-0.38	$-0.41	$-0.47	$-0.51	$-0.83	—	$-0.58	$-0.57	$-0.60	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Free Cash Flow per Share (USD)	$-0.21	$-0.25	—	$-0.23	—	$-0.24	—	—	—	—	—	—	$-0.34	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Book Value per Share (USD)	$4.07	$5.00	$5.24	$3.67	$3.96	$4.23	$4.50	$4.77	$4.40	$3.44	$3.80	$4.90	$4.46	$4.80	$3.82	$4.25	$3.92	$4.65	$5.21	—	—	$3.92	$3.41	$3.85	$4.49	$3.10	$3.85	—	—	—	$-40.10	—	—	—	—
Tangible Book Value per Share (USD)	$4.07	$5.00	$5.24	$3.67	$3.96	$4.23	$4.50	$4.77	$4.40	$3.44	$3.80	$4.90	$4.46	$4.80	$3.82	$4.25	$3.92	$4.65	$5.21	—	—	$3.92	$3.41	$3.85	$4.49	$3.10	$3.85	—	—	—	$-40.10	—	—	—	—
Basic Weighted Avg Shares (shares)	76.26M	76.22M	—	62.60M	62.54M	62.48M	—	62.41M	62.20M	61,984	—	61,823	61.79M	59,722	—	46,213	40,890	—	—	36,606	32,636	—	—	—	—	—	—	—	—	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Dec 31, 2017 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-K ↗
Working Capital (USD)	$312.55M	$328.81M	$344.43M	$194.23M	$210.39M	$224.46M	$238.88M	$252.98M	$267.59M	$207.26M	$228.52M	$248.41M	—	$288.42M	$190.79M	$213.03M	$152.13M	$181.78M	$206.80M	—	—	$124.36M	$92.78M	$105.66M	$120.84M	$70.14M	$87.94M	—	—	—	$69.87M	—	—	—	—
Total Equity (USD)	$310.70M	$333.30M	$349.00M	$198.37M	$214.38M	$228.49M	$243.03M	$257.29M	$273.79M	$213.59M	$235.19M	$255.46M	$275.43M	$296.26M	$198.94M	$221.41M	$160.75M	$189.16M	$211.54M	$230.61M	$110.89M	$127.75M	$95.18M	$104.98M	$122.13M	$70.63M	$87.15M	$102.13M	$-111.68M	$-99.69M	$-63.67M	$-55.58M	$-47.15M	$-33.27M	$-33.27M

📋 What is driving earnings? 4 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Dec 31, 2017 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-K ↗
Sales/Revenue/Turnover (USD)	—	—	—	$0.00	$0.00	—	—	$0.00	$80.00M	$0.00	—	$759.00K	$880.00K	$295.00K	—	$1.18M	$1.88M	$2.59M	—	$4.93M	$4.38M	$4.79M	—	$1.85M	$2.00M	$750.00K	—	—	—	—	—	—	—	—	—
Depreciation Expense (USD)	$200.00K	$338.00K	$347.00K	$300.00K	$300.00K	$353.00K	$369.00K	$400.00K	$400.00K	$479.00K	$508.00K	$500.00K	$600.00K	$566.00K	$591.00K	$600.00K	$700.00K	$536.00K	$621.00K	$600.00K	$700.00K	$603.00K	$733.00K	$500.00K	$600.00K	$539.00K	$519.00K	$500.00K	$500.00K	$504.00K	$509.00K	$400.00K	$200.00K	—	—
Net Income, GAAP (USD)	$-18.89M	$-18.89M	$-20.33M	$-17.66M	$-17.66M	$-17.66M	$-16.57M	$-26.87M	$-26.87M	$-26.87M	$-24.76M	$-24.78M	$-24.78M	$-24.78M	$-26.14M	$-25.93M	$-25.93M	$-25.93M	$-23.48M	$-17.00M	$-17.00M	$-17.00M	$-17.72M	$-18.45M	$-18.45M	$-18.45M	$-16.12M	$-36.84M	$-36.84M	$-36.84M	$-8.86M	$-6.94M	$-6.94M	—	—
Operating Cash Flow (USD)	$-16.04M	$-18.75M	$-16.80M	$-14.19M	—	$-15.26M	$-16.76M	—	—	$-25.28M	$-23.16M	—	$-20.79M	$-24.12M	$-19.70M	—	$0.00	$-22.11M	$-21.86M	$-22.57M	$-17.82M	$-16.23M	$-19.83M	—	—	$-15.20M	$-4.50M	$-13.02M	$-12.07M	$-9.90M	$-6.40M	$-4.12M	—	—	—

Fulcrum Therapeutics, Inc.

Analytical Summary

35-Year Financial Trajectory

Health Breakdown

Statement lens

Benchmark Lens

Percentile Rankings

Peer Comparison

Compare FULC with peers